Keel Point’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
Keel Point's ATNM Position: Q3 2026 in Review
Keel Point opened a new position in Actinium Pharmaceuticals (ATNM) in Q3 2026: 41,094 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #567 among its holdings.
50 funds tracked by Wall St. Rank hold ATNM as of Q3 2026.
- Keel Point held 41,094 shares of Actinium Pharmaceuticals worth $46K as of Q3 2026.
- Actinium Pharmaceuticals was a new Keel Point position in Q3 2026.
- Actinium Pharmaceuticals made up ﹤0.01% of Keel Point's portfolio in Q3 2026, its #567 holding.
- 50 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2026.
Based on Keel Point's 13F filing for Q3 2026, filed 16 Nov 2026.